Park Nicollet Institute is a clinical research site located in Saint Louis Park, Minnesota, United States 55416.
Crixeo Health Trust Score: 84/100 (GOOD). This profile has not yet been claimed by the site owner.
Park Nicollet Institute has participated in 22 clinical trials with 2 currently active.
Therapeutic areas: Primary Prevention of Atherosclerotic Cardiovascular Disease, Prostate Cancer, AtrioVentricular Nodal Reentrant Tachycardia.
Sponsors: Novartis Pharmaceuticals, Novacea, Medtronic Cardiac Ablation Solutions.
Trust Score: 84/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Park Nicollet Institute has a Crixeo Trust Score of 84/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Park Nicollet Institute has 22 clinical trials on record, with 2 currently active. Their work covers Primary Prevention of Atherosclerotic Cardiovascular Disease, Prostate Cancer, AtrioVentricular Nodal Reentrant Tachycardia.
Yes — Park Nicollet Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.